8th Jun 2006 07:03
Advanced Medical Solutions Grp PLC08 June 2006 For Immediate Release 8 June 2006 Advanced Medical Solutions Group plc ("AMS" or "the Company") Strengthens its Intellectual Property Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the globalmedical technology company, today announces that it has strengthened its patentportfolio for its LiquiBand(TM) range of topical wound closure cyanoacrylateadhesives with the granting of a European patent to protect its Laparoscopicwound closure device. The patent covers a multi-tipped device used to initiallyclose and seal the wound and then used to apply a secondary liquid bandage. Theliquid bandage is used to protect the wound from bacteria, dirt and moistureduring healing without the need for secondary dressings. A patent covering thisdevice has previously been granted in the US. Commenting on this announcement Dr. Don Evans, Chief Executive of AMS, stated: "As a technology company it is critical that we develop strong intellectualproperty around our products. This latest patent strengthens our globalprotection around a key product in our wound closure portfolio. LiquiBandLaparoscopic(TM) offers real clinical and patient benefits in infection controland cosmetic outcomes for procedures conducted by key hole surgery. The productis approved for sale throughout Europe and is currently undergoing regulatoryapproval in US and Japan." -ENDS- For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508 Don Evans, Chief Executive Mary Tavener, Finance Director www.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000 Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $13 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS' resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives that offer benefits over sutures andstaples for closing wounds sold direct to hospitals or through distributors. AMS' technology and products currently serve the majority of the key globalmarkets and strategic partners. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group